跳至主要内容
临床试验/IRCT20151228025732N30
IRCT20151228025732N30招募中未知

The effect of dydrogesterone in prevention of preeclampsia in high-risk pregnancy of primigravidae women that has been referred to gynecology clinic

Semnan University of Medical Sciences0 个研究点目标入组 168 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Women that have aged 18 to 40 years
  • Nulliparous Women
  • The body mass index is equal to or greater than 30 kg / m2

排除标准

  • The history of consumption of progesterone supplements in the last 6 months
  • Contraindications for the use of progesterone
  • Use of drugs that induce liver enzymes activation (carbamazepine, phenytoin and rifampin)
  • Diagnosis of embryonic anomalies by ultrasound
  • Previous cases of systemic diseases, such as asthma, diabetes, liver and kidney disorders, cardiovascular disease, connective tissue diseases.

研究者

发起方
Semnan University of Medical Sciences

相似试验